Soluble VEGFR-2 as an Endogenous Inhibitor of Retinal Lymphatics

  • Baffi, Judit (PI)

Grants and Contracts Details


The goals of this project are to (1) define the mechanisms underlying the alymphatic nature of the retina by developing novel insights into the biology of the endogenous lymphangiogenesis inhibitor soluble vascular endothelial growth factor receptor-2 (sVEGFR-2); and (2) enable the principal investigator to develop the skills and experiences necessary to become an independent physician-scientist with a focus on studying ocular angiogenesis.
Effective start/end date9/30/116/30/12


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.